Dividend Genmab A/S

Equities

GMAB

DK0010272202

Biotechnology & Medical Research

Real-time Estimate Cboe Europe Other stock markets 08:24:35 05/12/2025 GMT			5-day change	1st Jan Change
2,054.50 ^DKK	-0.36%		0.00%	+36.62%

12-04	Genmab A/S Presents at Citi Annual Global Healthcare Conference 2025, Dec-04-2025 09:45 AM
12-04	Genmab Closes $2.5 Billion Senior Notes Offering	MT

EPS & Dividend: Genmab A/S

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	72.21	45.54	83.65	66.02	121.4	117	105.7	142.7
Distribution rate	-	-	-	-	-	-	-	-
Reference price ²	2,463.00	2,630.00	2,941.00	2,155.00	1,492.50	2,062.00	2,062.00	2,062.00
Nbr of stocks (in thousands)	65,410	65,423	65,362	65,322	63,524	61,599	-	-
Announcement Date	23/02/21	16/02/22	22/02/23	14/02/24	12/02/25	-	-	-

¹DKK in Million²DKK

Estimates

Upcoming events: Genmab A/S

05/12/2025	American Society of Hematology Meeting - Abstract Number:7251
05/12/2025	American Society of Hematology Meeting - Abstract Number:8075
05/12/2025	American Society of Hematology Meeting - Abstract Number:7942
06/12/2025 15:00	American Society of Hematology Meeting - Abstract No:63
06/12/2025 15:15	American Society of Hematology Meeting - Abstract No:64
06/12/2025 22:30	American Society of Hematology Meeting - Abstract No:1820
06/12/2025 22:30	American Society of Hematology Meeting - Abstract No:1955
06/12/2025 22:30	American Society of Hematology Meeting - Abstract No:1959
06/12/2025 22:30	American Society of Hematology Meeting - Abstract No:1960
06/12/2025 22:30	American Society of Hematology Meeting - Abstract No:2721
06/12/2025 22:30	American Society of Hematology Meeting - Abstract No:3565
07/12/2025 14:45	American Society of Hematology Meeting - Abstract No:464
07/12/2025 15:00	American Society of Hematology Meeting - Abstract No:465
07/12/2025 15:15	American Society of Hematology Meeting - Abstract No:466
07/12/2025 23:00	American Society of Hematology Meeting - Abstract No:3736

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Dividend Yield (N)	Dividend Yield (N+1)	P/E (N)	Price to Book (N)	EV / Sales (N)
	GENMAB A/S	-.--%	-.--%	17.63x	3.33x	4.35x
	ARGENX SE	-.--%	-.--%	51.47x	8.37x	12.55x
	INSMED INCORPORATED	-.--%	-.--%	-33.26x	66.46x	84.43x
	WUXI APPTEC CO., LTD.	1.79%	1.69%	15.85x	3.74x	5.55x
	BIONTECH SE	-.--%	-.--%	-25.43x	1.1x	3.36x
	WUXI BIOLOGICS (CAYMAN) INC.	-.--%	-.--%	27.78x	2.57x	5.44x
	SUMMIT THERAPEUTICS INC.	-.--%	-.--%	-14.56x	-	183.27x
	AKESO, INC.	-.--%	-.--%	-510.49x	13.99x	29.53x
	MADRIGAL PHARMACEUTICALS, INC.	-.--%	-.--%	-59.75x	22.06x	13.44x
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-.--%	-.--%	-192.29x	23.23x	47.41x
	Average	0.18%	0.17%	-72.30x	16.09x	38.93x
	Weighted average by Cap.	0.27%	0.25%	-34.40x	18.63x	34.51x

See all sector dividends

Year-on-year evolution of the Yield

Dividend / Share (DPS) - Evolution of Analysts' Estimates

More analyst reviews

Dividend / Share (DPS) - Estimates Revisions

More analyst reviews

Earnings Per Share (EPS) - Evolution of Analysts' Estimates

More analyst reviews

Annual Profit -

Company calendar

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Unlock them now!